Amaral Eliana, Norcini John
Obstetrics and Gynecology Department, UNICAMP, Campinas, Sao Paulo, Brazil.
FAIMER, Philadelphia, Pennsylvania, USA.
Med Educ. 2023 Jan;57(1):40-48. doi: 10.1111/medu.14880. Epub 2022 Jul 29.
The aim of this paper is to provide an overview of the major quality assurance strategies, accreditation and licensure, in health professions education. It explores the nature of these regulatory processes using Brazil and the United States as examples because these large systems are at different ends of the developmental continuum. For each, it describes the tensions that arise, offers a critical synthesis of the evidence and maps out future directions.
Given wide variability among operating medical schools in curricular design, length of study, resources and facilities for clinical training and supervision, the nature of regulatory bodies varies considerably. Nonetheless, they share tensions related purpose and process including quality assurance versus quality improvement, outcomes versus process and continuous versus episodic evaluations and assessments. Clear evidence of effectiveness, especially for accreditation, is scarce and difficult to obtain, particularly as it relates to health outcomes.
Regulatory processes need to be built around clear definitions of the goals for each stage of professional development, the current movement towards competency-based education and the variable durations of medical education. These changes must motivate revisions in the content and process of programmes for accreditation and licensure, complimentary efforts towards quality of care, and stimulate a significant research effort.
本文旨在概述卫生专业教育中的主要质量保证策略、认证和许可情况。以巴西和美国为例探讨这些监管过程的性质,因为这两个大体系处于发展连续体的不同端点。针对每个国家,本文描述了所出现的矛盾,对证据进行了批判性综合分析,并规划了未来方向。
鉴于各医学院校在课程设计、学习时长、临床培训和监督的资源与设施方面存在很大差异,监管机构的性质也有很大不同。尽管如此,它们在目的和过程方面存在共同的矛盾,包括质量保证与质量改进、结果与过程以及持续评估与定期评估。关于有效性的明确证据,尤其是认证方面的证据,稀缺且难以获得,特别是与健康结果相关的证据。
监管过程需要围绕专业发展各阶段目标的明确定义、当前基于能力的教育趋势以及医学教育的不同时长来构建。这些变化必须促使对认证和许可程序的内容与过程进行修订,对医疗质量做出补充努力,并推动大量的研究工作。